SMM Global – Stock Market Manager Stock Market Manager simplifies distribution and disclosure of press releases, research and corporate news to financial terminals, print, broadcast and trade media, wire services, news agencies, databases, portals and websites.
Coeptis Therapeutics COEP
Coeptis Therapeutics Holdings, Inc. (NASDAQ: COEP), together with its subsidiaries (including Coeptis Therapeutics, Inc. and Coeptis Pharmaceuticals, Inc., (collectively “Coeptis”), is a biopharmaceutical company developing innovative cell therapy platforms for patients with cancer. Coeptis was founded in 2017 and is headquartered in Wexford, PA.
7-17-2023 International Food and Beverage (OTC IFBC)
Italian Food & Beverage Corp. Announces Strategic Partner IFBC is now an approved vendor for Ferraro Foods, one of the country’s largest specialty distributors of food and foodservice supplies to …
Stock Market Manager Weekly Update: July 18th, 2023
Weekly Update: July 18th, 2023 Black Swan Connection Newsletter Signup Breaking News There are some signs that inflation is easing. After more than two years of rising prices, the rate of …
Stock Market Manager Weekly Update: July 10th, 2023
Weekly Update: July 10th, 2023 Black Swan Connection Newsletter Signup Breaking News Nasdaq rebalance is coming July 24th, but what does it all mean??? The magnificent 7 which makes up 55% …
Description
Coeptis Therapeutics Holdings, Inc. (NASDAQ: COEP), together with its subsidiaries (including Coeptis Therapeutics, Inc. and Coeptis Pharmaceuticals, Inc., (collectively “Coeptis”), is a biopharmaceutical company developing innovative cell therapy platforms for patients with cancer. Coeptis was founded in 2017 and is headquartered in Wexford, PA.
Contact Information
105 Bradford Rd
Suite 420
Wexford, PA 15090
Financial Reporting/Disclosure
Reporting Status : U.S. Reporting: SEC Reporting
Latest Report : 12/31/22 10-Q
CIK : 0001759186
Fiscal Year End : 12/31
NASDAQ : COEP
Profile Data
SIC – Industry Classification : Not Available
Incorporated In : NV, USA
Year of Inc. : Not Available
Employees : Not Available
Company Officers/Contacts
Dave Mehalick ┃ Chairman, President and Chief Exec. Officer
Christine Sheehy ┃ CFO
Dan Yerace┃ Director and VP of Operations
Dr. Everin Alici Ph.D., MD ┃ Head of Gene Cell Therapy Group
Dr. Hans-Gustaf Ljunggren Ph.D., MD ┃